2011
DOI: 10.3174/ajnr.a2550
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic Abnormalities in Pain-Processing Regions of Patients with Fibromyalgia: A 3T MR Spectroscopy Study

Abstract: BACKGROUND AND PURPOSE:A growing body of evidence suggests the involvement of the brain in FM. The purpose of this proton MRS study was to test the hypothesis that there are metabolic alterations in some brain regions processing pain (VLPFC and thalamus) in patients with FM compared with HC.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
42
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(48 citation statements)
references
References 37 publications
5
42
0
1
Order By: Relevance
“…Given the role of the lateral prefrontal cortex in high-level pain-modulatory mechanisms, our findings suggest the possibility that catastrophizing induces hyperalgesia by disrupting the adaptive recruitment of vIPFC/alPFC-dependent pain-inhibitory processes, which normally attenuate the effects of incoming painful stimulation. Of note, altered vIPFC physiology in FM has also been reported using magnetic resonance spectroscopy, which demonstrated neurochemical alterations (i.e., increased glutamate/glutamine concentration) in this region 9 . Thus, our results provide further evidence implicating lateral prefrontal cortex in FM pathophysiology.…”
Section: Discussionmentioning
confidence: 65%
“…Given the role of the lateral prefrontal cortex in high-level pain-modulatory mechanisms, our findings suggest the possibility that catastrophizing induces hyperalgesia by disrupting the adaptive recruitment of vIPFC/alPFC-dependent pain-inhibitory processes, which normally attenuate the effects of incoming painful stimulation. Of note, altered vIPFC physiology in FM has also been reported using magnetic resonance spectroscopy, which demonstrated neurochemical alterations (i.e., increased glutamate/glutamine concentration) in this region 9 . Thus, our results provide further evidence implicating lateral prefrontal cortex in FM pathophysiology.…”
Section: Discussionmentioning
confidence: 65%
“…Since MRS may not accurately measure glutamate (Glu), it is customary to report combined Glu + glutamate (Glx) levels. Greater concentrations of Glx, higher Glx/Cr ratios or both have been detected in a variety of brain regions of FMS compared to healthy subjects [296,297,[304][305][306]. Unfortunately, not only the regions investigated with MRS, but also the regions identified as showing elevated Glx levels vary from one study to the next even when performed by the same group of researchers [296,297,[304][305][306].…”
Section: Neuroendocrine and Cytokine Disturbances Brain Neurochemistrymentioning
confidence: 89%
“…Unfortunately, not only the regions investigated with MRS, but also the regions identified as showing elevated Glx levels vary from one study to the next even when performed by the same group of researchers [296,297,[304][305][306]. This is regrettable because more detailed knowledge of the localization of increased Glx activity could provide insights into the role of Glu in the pathophysiology of FMS, particularly since elevated Glx concentrations in certain brain areas are associated with clinical pain severity, pain sensitivity, and various other symptoms of FMS [296,297,[304][305][306]. After long-term non-pharmacological treatment, the magnitude of the decline in the Glu/Cr ratio of the posterior insula correlated with the magnitude of the decrease in clinical pain and increase of the experimental pressure pain threshold [307].…”
Section: Neuroendocrine and Cytokine Disturbances Brain Neurochemistrymentioning
confidence: 96%
See 1 more Smart Citation
“…También se han encontrado elevados niveles de Cho en la CPF dorsolateral con una relación positiva del dolor espontáneo referido (82), con resultados más contradictorios de los niveles de dicho metabolito en el hipocampo (47). Estudios más recientes han focalizado su atención en el papel del Glu/Glx en la FM (47), objetivándose un incremento del nivel de Glx en la INS posterior (83) que puede reducirse tras tratamiento con acupuntura (84), en la amígdala derecha (85), en la CPP (86) y en la CPF ventro-lateral (87). Esta heterogénea distribución neuroanatómica de elevados niveles de Glx puede sugerir que dicho metabolito juegue un papel en la variada sintomatología de la FM (47).…”
Section: Alteraciones Molecularesunclassified